| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.006 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |